Home > Products > CD3 & VEGFR2
> Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv-Fc)
Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-109)
Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD3 specificity or anti-VEGFR2 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Non-small cell lung cancer (NSCLC); Glioblastoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv-Fc) (BSCFV-109). Click the button below to contact us or submit your feedback about this product.